Guangdong Lifestrong Pharmacy Co., Ltd. (SHE:301111)
China · Delayed Price · Currency is CNY 21.39
-0.55 (-2.51%)
Sep 10, 2026, 3:04 PM CST
SHE:301111 Revenue
Guangdong Lifestrong Pharmacy had revenue of 78.58M CNY in the quarter ending June 30, 2026, a decrease of -6.41%. This brings the company's revenue in the last twelve months to 304.63M, up 8.39% year-over-year. In the year 2025, Guangdong Lifestrong Pharmacy had annual revenue of 314.64M with 12.92% growth.
Revenue (ttm)
304.63M
Revenue Growth
+8.39%
P/S Ratio
11.52
Revenue / Employee
527.03K
Employees
578
Market Cap
3.51B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 314.64M | 36.00M | 12.92% |
| Dec 31, 2024 | 278.64M | -13.76M | -4.71% |
| Dec 31, 2023 | 292.40M | 9.06M | 3.20% |
| Jan 1, 2023 | 283.34M | -66.45M | -19.00% |
| Jan 1, 2022 | 349.79M | 8.83M | 2.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 23.66B |
| Zhejiang Starry Pharmaceutical | 2.46B |
| Nanjing Well Pharmaceutical Group | 1.40B |
| Zhuhai Rundu Pharmaceutical | 1.34B |
| Harbin Medisan Pharmaceutical | 805.09M |
| Nanjing Hicin Pharmaceutical | 726.62M |
| Shaanxi Kanghui Pharmaceutical | 429.09M |
| Lionco Pharmaceutical Group | 408.33M |